Zobrazeno 1 - 10
of 13
pro vyhledávání: '"E S, Ganotakis"'
Autor:
E. L. Lioudaki, E. S. Ganotakis
Publikováno v:
The Open Clinical Chemistry Journal. 3:25-37
Cardiovascular disease (CVD) remains a leading cause of global morbidity and mortality despite identification of major cardiovascular (CV) risk factors and risk reduction via appropriate interventions. During the last years several markers have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bee4a09ed93cbde6be6343cf012a0b56
https://doi.org/10.2174/1874241601003020025
https://doi.org/10.2174/1874241601003020025
Autor:
E. S. Ganotakis, Joanna Moschandrea, Miltiadis K. Tsilimbaris, E. Nitoda, A. Pallikaris, G. Amoiridis, P. Kallinikos
Publikováno v:
Current eye research. 37(10)
To employ corneal confocal microscopy to assess differences in the extent of corneal nerve fiber alterations between diabetic patients classed according to retinopathy status and nondiabetic patients.Two hundred seventy-eight corneas of 139 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e87b09d212ad8f8d9d653d33051c28eb
https://pubmed.ncbi.nlm.nih.gov/22632054
https://pubmed.ncbi.nlm.nih.gov/22632054
Autor:
J A, Papadakis, P I, Sidiropoulos, S A, Karvounaris, G E, Vrentzos, E K, Spanakis, E S, Ganotakis, H D, Kritikos, D P, Mikhailidis, D T, Boumpas
Publikováno v:
Clinical and experimental rheumatology. 27(2)
Ankylosing spondylitis (AS) may be associated with an increased risk for cardiovascular diseases (CVD). We investigated the prevalence of cardiovascular risk factors and metabolic syndrome (MetS) in men with AS and assessed any correlation with AS-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0759938195444f221953af6fbe4ea64e
https://pubmed.ncbi.nlm.nih.gov/19473571
https://pubmed.ncbi.nlm.nih.gov/19473571
Autor:
G E, Vrentzos, J A, Papadakis, E S, Ganotakis, K I, Paraskevas, I F, Gazi, N, Tzanakis, D R, Nair, D P, Mikhailidis
Publikováno v:
International journal of clinical practice. 61(10)
To compare the Framingham and Prospective Cardiovascular Munster (PROCAM) risk calculations.We calculated the risk in 234 dyslipidaemic patients without overt vascular disease and in different subgroups. For example, the proportion of patients with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76c033cc607501836271c24778208ac7
https://pubmed.ncbi.nlm.nih.gov/17877651
https://pubmed.ncbi.nlm.nih.gov/17877651
Publikováno v:
Clinical and experimental rheumatology. 25(1)
Atherosclerosis may be more prevalent and more extensive in individuals with rheumatoid arthritis (RA) compared with the general population. Despite the fact that traditional and novel cardiovascular disease (CVD) risk factors are clinically importan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff68b9133954da3ba0a72d2078d18c2b
https://pubmed.ncbi.nlm.nih.gov/17418000
https://pubmed.ncbi.nlm.nih.gov/17418000
Autor:
D. Papakonstandinou, K. Liakou, Dimitri P. Mikhailidis, M. Zidianakis, E. S. Ganotakis, G. Avramakis, A. Dermitzakis, E. Papadimitraki
Publikováno v:
Platelets. 18(1)
Platelet (PLT)-endothelial cell and PLT-leukocyte interactions at lesion-prone sites might trigger a local inflammatory response early in the genesis of atherosclerosis and contribute to plaque destabilization leading to acute coronary syndromes (ACS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e12ab51c0efb99dd41823a570cf4f87
https://pubmed.ncbi.nlm.nih.gov/17365849
https://pubmed.ncbi.nlm.nih.gov/17365849
Autor:
N. Malliaraki, E. S. Ganotakis, G. E. Vrentzos, E. G. Petinellis, A. Repa, J. A. Papadakis, D. E. Bampalis, V. Lemonomichelaki
Publikováno v:
Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. 19(2)
Background Dietary habits are an important determinant of serum homocysteine (tHcy), which may be a marker rather than a cause of progression of the atherosclerotic process. The aim of the present study was to evaluate the nutritional status, and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0066fb758eea833c263df7a35f36b2d3
https://pubmed.ncbi.nlm.nih.gov/16533373
https://pubmed.ncbi.nlm.nih.gov/16533373
Autor:
M G, Alexandrakis, F H, Passam, E S, Ganotakis, K, Sfiridaki, I, Xilouri, K, Perisinakis, D S, Kyriakou
Publikováno v:
Clinical and laboratory haematology. 25(1)
Interleukin-6 (IL-6) and acute phase proteins are commonly increased in patients with multiple myeloma. Several of these acute phase proteins are believed to predict prognosis and influence survival. We measured interleukin-6 (IL-6), C-reactive prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::56c348438b165fc0cbd70442b2ab30b1
https://pubmed.ncbi.nlm.nih.gov/12542441
https://pubmed.ncbi.nlm.nih.gov/12542441
Publikováno v:
International angiology : a journal of the International Union of Angiology. 21(1)
Bilirubin and albumin may act as antioxidants. Their circulating levels are lower in those patients with ischemic heart disease (IHD) and could be further reduced by more extensive atherosclerosis, i.e. peripheral vascular disease (PVD).Serum bilirub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2002699991b8b1d198cf9e8dec48bad4
https://pubmed.ncbi.nlm.nih.gov/11941273
https://pubmed.ncbi.nlm.nih.gov/11941273
Publikováno v:
International journal of cardiology. 69(3)
We evaluated the use of combination therapy (ciprofibrate 100 mg or bezafibrate 400 mg plus fluvastatin 40 mg) in 23 patients (n = 13 in the ciprofibrate group) with established cardiovascular disease. Both treatments achieved a significant (Por =0.0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::870c3fe6be4d8d3e20690b470f5ef73a
https://pubmed.ncbi.nlm.nih.gov/10636539
https://pubmed.ncbi.nlm.nih.gov/10636539